Determination of the Glycemic Index Values of 10 Cereal-based Products

November 26, 2024 updated by: PepsiCo Global R&D
To determine the Glycemic index values for 10 cereal-based products

Study Overview

Detailed Description

To determine the Glycemic index values for 10 cereal-based products per international standard (ISO26642:2010) for glycemic index determination.

Study Type

Interventional

Enrollment (Actual)

10

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • New South Wales
      • Sydney, New South Wales, Australia, 2006
        • Sydney University's Glycemic Index Research Service (SUGiRS)

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • 10 healthy participants, male and female (non-pregnant, non-lactating) of mixed ethnicity, aged between 18 - 65 y
  • BMI: 18 - 25.0 kg/m2 (bounds included)
  • Non smokers
  • Normal glucose tolerance (assessed by 50 gram oral glucose tolerance test performed within the last 30 days: fasting <6 mM, 2 hr glucose <7.8 mM)
  • Stable weight and dietary habits. Normal eating patterns and no history of eating disorders or recent dieting
  • Normal sleep patterns (ie. at least 6 hours of sleep per night)
  • The participants are required to avoid alcohol and unusual levels of food intake and physical activity for the 24 hours before each test session.
  • Absence of health conditions that would prevent fulfillment of study requirements as judged by the Investigator on the basis of medical history. Understanding the study procedures and willing to provide informed consent to participate in the study and authorization to release relevant protected health information to the study investigator.

Exclusion Criteria:

  • Food allergy or intolerance to the study ingredients (eg. gluten, etc.)
  • Regularly taking prescription medication other than standard contraceptive medication
  • Taking any medications known to affect glucose tolerance (eg. acetylsalicylic acid, thyroxin, vitamins and mineral supplements or drugs to treat hypertension or osteoporosis)
  • Suffering from any illness or disease
  • Following a restricted diet
  • Smokers
  • Eating disorders
  • Abnormal glucose tolerance or known history of diabetes mellitus.
  • Individuals currently participating in other acute metabolic studies
  • Failure to meet any one of the inclusion criteria

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Basic Science
  • Allocation: Randomized
  • Interventional Model: Crossover Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Reference food
Glucodin powder solution
Glucodin powder diluted with water
Experimental: Food 1
Quaker Whole Oats
Variety of cooked or flake cereal
Experimental: Food 2
Quaker Quick Cooking White Oats
Variety of cooked or flake cereal
Experimental: Food 3
Saffola Oats
Variety of cooked or flake cereal
Experimental: Food 4
Quaker Oats
Variety of cooked or flake cereal
Experimental: Food 5
Quaker Oats Multigrain
Variety of cooked or flake cereal
Experimental: Food 6
Ragi Flakes
Variety of cooked or flake cereal
Experimental: Food 7
Bajra Flakes
Variety of cooked or flake cereal
Experimental: Food 8
Jowar Flakes
Variety of cooked or flake cereal
Experimental: Food 9
Maltabella
Variety of cooked or flake cereal
Experimental: Food 10
FutureLife Smart + White Oats
Variety of cooked or flake cereal

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Glycemic index (GI) values
Time Frame: Two hour test session per visit. Visits must be at least two days apart. Including Screening, the study duration is approximately four to eleven weeks depending on whether participants are available to be tested one, two or three times per week.
Comparison of Glycemic index (GI) values of 10 different cereal-based products and the reference food (glucose solution assigned GI=100 by definition)
Two hour test session per visit. Visits must be at least two days apart. Including Screening, the study duration is approximately four to eleven weeks depending on whether participants are available to be tested one, two or three times per week.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Richa Bharti, MS, PepsiCo R&D Life Sciences

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

July 1, 2024

Primary Completion (Actual)

September 27, 2024

Study Completion (Actual)

September 27, 2024

Study Registration Dates

First Submitted

November 25, 2024

First Submitted That Met QC Criteria

November 26, 2024

First Posted (Actual)

November 29, 2024

Study Record Updates

Last Update Posted (Actual)

November 29, 2024

Last Update Submitted That Met QC Criteria

November 26, 2024

Last Verified

November 1, 2024

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Diabetes

Clinical Trials on Glucose solution Day 1, Day 8, and Day 15

Subscribe